Mission Statement
EVMA aims to enhance vaccine production capabilities in Egypt and support public health objectives across Africa.
Institutionalization of the EVMA Governance Framework
The Egyptian Vaccine Manufacturers Alliance (EVMA) announces the issuance of Ministerial Decree No. 449 of 2025, establishing the EVMA Committee as the formal national governance mechanism for coordinating vaccine manufacturing efforts in Egypt.
This decree marks a significant milestone in the evolution of EVMA. The Alliance has transitioned from a strategic coordination platform into a formally institutionalized national governance body, reinforcing Egypt’s commitment to strengthening its vaccine manufacturing ecosystem and supporting regional health security.
Dr. Amr Kandil
Deputy Ministry of Health and Population for Preventive Medicine and Primary Care
&
Head of EVMA
Mandate of the EVMA Committee
Under the decree, the EVMA Committee will undertake the following key responsibilities:
- Develop a Unified National Vaccine Manufacturing Strategy
- Formulate and oversee the implementation of a national strategy for vaccine manufacturing that addresses local and regional needs.
- Consider the current capacities of national vaccine manufacturers, while proposing mechanisms for their development.
- Support technology transfer and localization, and enhance national production capabilities.
- Strengthen Partnerships Among Vaccine Manufacturers
- Promote collaboration and strategic partnerships between manufacturers to ensure the optimal use of national resources and capabilities.
- Monitor Domestic Vaccine Supply and Demand
- Track the needs of the local vaccine market and propose necessary measures to address potential shortages or supply gaps.
The establishment of the EVMA Committee provides a structured governance framework to guide policy implementation, coordinate stakeholders, and align national vaccine manufacturing initiatives under a unified roadmap.
Through this institutional framework, EVMA will continue to support Egypt’s vision of becoming a regional hub for vaccine production and innovation, contributing to sustainable access to vaccines and enhanced public health resilience across Africa and the region.
2nd African Vaccine and Other health products Manufacturing Forum: African Leaders Unite to Forge Vaccine Strategies, Spotlighting EVMA
Conference Launch Highlights
On Wednesday, 27 November 2024, the Egyptian Vaccine Manufacturers Alliance (EVMA) proudly hosted its Launch Conference at the prestigious Marriott El Zamalek from 10 AM to 4 PM.
This conference featured the presence of
Read more
Don't miss out on this opportunity
Apply NOW to Africa CDC's Biomanufacturing Fellowship Program
Launched under the Platform for Harmonized African Health Products Manufacturing, this programme supports a bold continental vision to scale up local production of vaccines, diagnostics, and therapeutics—essential for building resilient health systems and reducing Africa’s reliance on external supply.
Deadline: 30 May 2025
